Physician profile
Michael B Simpson
NPI 1457373011
$13,427.90
in general payments reported to CMS, 2019-2025
12 companies · $228 in 2025
The $228 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,329 · 2020: $470 · 2021: $6,263 · 2022: $198 · 2023: $634 · 2024: $306 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,167.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $9,059.02 | 2019-2023 | Distal Extremities Implants Soft Tissue Ib Ligament Augmentation |
| Gemini Mountain Medical, LLC | $2,707.68 | 2019-2021 | |
| Stryker Corporation | $698.57 | 2020-2025 | Flexband, 1688, Alphavent |
| Smith+Nephew, INC. | $415.42 | 2020-2024 | Bone Anchors With Arthroscopic Delivery System, Lens 4k, Q-Fix |
| Ossio INC | $210.46 | 2023 | |
| Orthofix Medical, INC. | $120.47 | 2021-2024 | Physio-Stim |
| Wright Medical Technology, INC. | $64.85 | 2019 | |
| Depuy Synthes Sales INC. | $46.59 | 2019-2024 | Orthovisc, Monovisc |
| Ferring Pharmaceuticals INC. | $32.75 | 2022-2025 | Euflexxa |
| Bioventus LLC | $30.28 | 2022-2025 | Xcell |
| Zimmer Biomet Holdings, INC. | $24.47 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $17.34 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.